| 788 |
Halogenated Hydrocarbons
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 789 |
terfenadine
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 790 |
Flecainide
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 791 |
Bupivacaine
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 792 |
Tetracaine
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 793 |
Saxitoxin
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 794 |
Tetrodotoxin derivatives
|
|
553: Inhibition of Voltage-gated sodium channels (Na⁺ channels) leading to heart failure
|
| 796 |
Epinephrine
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 797 |
Norepinephrine
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 798 |
Theophylline
|
|
554: β-adrenergic receptor agonists leading to arrhythmias.
|
| 800 |
Sotalol
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 801 |
Dofetilide
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 802 |
ziprasidone
|
|
555: Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure
|
| 804 |
Digoxin
|
|
556: Decreased Na/K ATPase activity leading to heart failure
|
| 805 |
Ouabain
|
|
556: Decreased Na/K ATPase activity leading to heart failure
|
| 806 |
Thapsigargin
|
|
556: Decreased Na/K ATPase activity leading to heart failure
|
| 807 |
Enoximone
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 808 |
Roflumilast
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 809 |
Catecholamines
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 810 |
Forskolin
|
|
558: Phosphodiesterase inhibition leading to heart failure
|
| 813 |
Donepezil
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 814 |
Neostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 815 |
Pyridostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 816 |
Diazinon
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 817 |
Sarin
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|